Prevalence of Human Immunodeficiency Virus among Presumptive Tuberculosis Patients Offered HIV Testing Services in Federal Capital Territory, Abuja Nigeria

Download Article

DOI: 10.21522/TIJPH.2013.10.04.Art026

Authors : Tangkat Friday Hosle, Nanbot Hosle, Doris Atibinye Dotimi


Human Immunodeficiency Virus has a prevalence of 1.4% in Nigeria, 2.0% in North Central Nigeria and, 1.4% among adults in Abuja. This study determined prevalence and predictors of Human Immunodeficiency Virus among 737 presumptive tuberculosis patients in Federal Capital Territory Abuja Nigeria from 1st April 2019 to 30th May 2021 through retrospective cross-sectional study and multi-stage sampling. From Non-Municipal Area Councils, Bwari was selected while from Health Facilities, General Hospital Bwari and Gwarimpa were selected from Bwari and Abuja Municipal Area Council respectively by simple random sampling and data abstractions were done and analyzed using Statistical Package for Social Sciences version 23.0 Software. The prevalence of Human Immunodeficiency Virus amongst patients with known status was 29.0%, unknown status 1.9% while their cumulative prevalence was 30.7%. The prevalence of Human Immweredeficiency Virus amongst patients with tuberculosis was 1.1%. Factors associated with Human Immunodeficiency Virus were Area Council (p = 0.001), age (p = 0.001) and gender (p = 0.001). For predictors, residency in Bwari was 0.196 times less likely compared to residency at AMAC, Abuja and, place of Residence was a predictor (aOR = 0.001; 95% C.I. = 0.130-295). The age group 31-40 years were 2 times more likely compared to other age groups and, age it was predictor (aOR = 0.019; 95% C.I. = 1.125-3.852). and male gender gender were 0.601 time less likely compared to females and, gender is a predictor (aOR = 0.021; 95% C.I. = 0.391-0.925).

Keywords: Human Immunodeficiency Virus, Presumptive, Tuberculosis.


[1] Nigerian AIDS Control Agency. (2020). About HIV/AIDS - NACA Nigeria. Retrieved April 11, 2021, from

[2] World Health Organization. (n.d.). HIV/AIDS. Retrieved April 11, 2021, from

[3] World Health Organization. (2018). HIV/AIDS | WHO | Regional Office for Africa. Retrieved April 11, 2021, from

[4] World Health Organization. (n.d.). HIV/AIDS. Retrieved April 11, 2021, from

[5] UNAIDS. (2020). Global HIV & AIDS statistics — 2020 fact sheet | UNAIDS. Retrieved April 12, 2021, from

[6] International Labour Organization. (n.d.). HIV/AIDS in Africa (Africa). Retrieved April 11, 2021, from

[7] Birdthistle, I., Schaffnit, S. B., Kwaro, D., Shahmanesh, M., Ziraba, A., Kabiru, C. W., Phillips-Howard, P., Chimbindi, N., Ondeng’E, K., Gourlay, A., Cowan, F. M., Hargreaves, J. R., Hensen, B., Chiyaka, T., Glynn, J. R., & Floyd, S. (2018). Evaluating the impact of the DREAMS partnership to reduce HIV incidence among adolescent girls and young women in four settings: A study protocol. BMC Public Health, 18(1).

[8] Centers for Disease Control and Prevention. (2020). Global Health - Newsroom - Tuberculosis. Retrieved April 10, 2021, from

[9] UNAIDS. (2019). New survey results indicate that Nigeria has an HIV prevalence of 1.4% | UNAIDS. Retrieved April 11, 2021, from

[10] NAIIS. (2019). Key findings. Retrieved April 12, 2021, from National Summary Sheet.pdf.

[11] NACA. (2019). Nigeria prevalence rate - NACA Nigeria. Retrieved April 12, 2021, from

[12] Slogrove, A. L., Schomaker, M., Davies, M. A., Williams, P., Balkan, S., Ben-Farhat, J., Calles, N., Chokephaibulkit, K., Duff, C., Eboua, T. F., Kekitiinwa-Rukyalekere, A., Maxwell, N., Pinto, J., Seage, G., Teasdale, C. A., Wanless, S., Warszawski, J., Wools-Kaloustian, K., Yotebieng, M.,Leroy, V. (2018). The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis. Plos Medicine, 15(3).

[13] World Health Organization. (2020). Tuberculosis. Retrieved March 30, 2021, from

[14] World Health Organization. (n.d.). Tuberculosis (TB) | WHO | Regional Office for Africa Organization. Retrieved April 11, 2021, from

[15] World Health Organization. (n.d.). Tuberculosis (TB) | WHO | Regional Office for Africa Organization. Retrieved April 11, 2021, from

[16] Federal Ministry of Health Nigeria. (2010). National Tuberculosis and Leprosy Control Programme: Workers’ manual – Revise 5th Edition 1. Retrieved April 2, 2021, from

[17] Hassan, A., Olukolade, R., Ogbuji, Q., Onyemocho, A., Okwuonye, L., Igbabul, S., Okechukwu, J., Kusimo, O., Osho, A., Osinowo, K., & Ladipo, O. (2016). Evaluation of Tuberculosis Treatment Outcome of TB/HIV Co-Infection: A Four-Year Retrospective Cohort Study in HIV-Prevalent Setting of North Central Nigeria. Journal of Tuberculosis Research, 04(03), 122–133.

[18] Dye, C., Harries, A. D., Maher, D., Hosseini, S. M., Nkhoma, W., & Salaniponi, F. M. (2006). Tuberculosis. In Disease and Mortality in Sub-Saharan Africa. The International Bank for Reconstruction and Development / The World Bank.

[19] Nwokoro, U. U., Dahiru, T., Olorukooba, A., Daam, C. K., Waziri, H. S., Adebowale, A., Waziri, N. E., & Nguku, P. (2020). Determinants of perinatal mortality in public secondary health facilities, Abuja municipal area council, Federal Capital Territory, Abuja, Nigeria. Pan African Medical Journal, 37(114), 1–12.

[20] Federal Capital Territory. (2019). Federal Capital Territory (FCT) Health Sector Resource Mobilisation Plan (2018–2022).

[21] Hamisu, A. W., Etapelong, S. G., Ayodeji, I. H., Furera, Z., Ningi, N., Jimoh, A., Fiona, B., Banda, R., Tegegne, S. G., Ajogwu, A., Nwachukwu, J., John, D., Abdurrahman, S., Ahmed, F., Adesola, L., Teresa, N., Adesola, O., Rahmat, A., Elizabeth, A., & Lydia, T. (2020). Assessment of the contribution of community active surveillance to covid-19 case detection in the Federal Capital Territory, Abuja, Nigeria. African Journal of Biology and Medical Research, 3(2), 98–110.

[22] Kamweli, M., Id, A., Kwaga, J., Okolocha, E., & Mba, N. (2019). Prevalence and risk factors for multi-drug resistant Escherichia coli among poultry workers in the Federal Capital Territory , Abuja , Nigeria Prevalence and risk factors for multi-drug resistant Escherichia coli among poultry workers in the Federal Capit. November.

[23] Kyaw, K. W. Y., Kyaw, N. T. T., Kyi, M. S., Aye, S., Harries, A. D., Kumar, A. M. V., Oo, N. L., Satyanarayana, S., & Aung, S. T. (2020). HIV testing uptake and HIV positivity among presumptive tuberculosis patients in Mandalay, Myanmar, 2014-2017. Plos One, 15(6), e0234429.

[24] Kumar, A. M., Gupta, D., Kumar, A., Gupta, R. S., Kanchar, A., Rao, R., Shastri, S., Suryakanth, M. D., Rangaraju, C., Naik, B., Guddemane, D. K., Bhat, P., Nair, A. S., Harries, A. D., & Dewan, P. (2016). HIV testing among patients with presumptive tuberculosis: How do we implement it in a routine programmatic setting? Results of a large operational research from India. PLoS ONE, 11(5), e0156487.

[25] Dlodlo, R. A., Hwalima, Z. E., Sithole, S., Takarinda, K. C., Tayler-Smith, K., & Harries, A. D. (2015). Are HIV-positive presumptive tuberculosis patients without tuberculosis getting the care they need in Zimbabwe? Public Health Action, 5(4), 217–221.

[26] Wasihun, A. G., Dejene, T. A., & Hailu, G. G. (2020). Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study. PLoS ONE, 15(11 November), e0240361.

[27] MacPherson, P., Lebina, L., Motsomi, K., Bosch, Z., Milovanovic, M., Ratsela, A., Lala, S., Variava, E., Golub, J. E., Webb, E. L., & Martinson, N. A. (2020). Prevalence and risk factors for latent tuberculosis infection among household contacts of index cases in two South African provinces: Analysis of baseline data from a cluster-randomised trial. PLOS ONE, 15(3), e0230376.

[28] Gelaw, B., Tigabu, A., Tadesse, T., Tegegne, Z., Hailu, W., Mahmud, E., Sisay, T., & Sendeku, W. (2021). Mycobacterium tuberculosis and HIV co-infection among presumptive tuberculosis cases and asthmatic patients at university of gondar hospital, northwest ethiopia. Clinical Laboratory, 67(1), 1–8.

[29] NACA. (2020). About HIV/AIDS - NACA Nigeria. Retrieved April 11, 2021, from

[30] Okonko, I. O., Ejike, I. U., Innocent-Adiele, C., & Cookey, T. I. (2020). HIV coinfections with tuberculosis among HIV-1 infected individuals in old cross river state, Nigeria. Journal of Immunoassay and Immunochemistry, 41(3), 245–256.

[31] Ibrahim, M. A., Abdulkadir, B., Y. Y. Riko, Farida, A. T., Mujahid, H., Ezekiel, B. K., Usman, A., Ahmad, M. A., Isah, M. G. and Murtala, S. (2020). A Survey on Tuberculosis and HIV Co-Infection among Presumptive Tuberculosis Patients within Zuru Emirate Council, Kebbi State, Nigeria. Nigerian Journal of Microbiology, 34(2), 5380–5389.

[32] Nutor, J.J., Duah, H.O., Agbadi, P. et al. (2020). Spatial analysis of factors associated with HIV infection in Malawi: indicators for effective prevention. BMC Public Health 20, 1167.

[33] Anoubissi JdD, Gabriel EL, Kengne Nde C, Fokam J, Tseuko DG, Messeh A, et al. (2019) Factors associated with risk of HIV-infection among pregnant women in Cameroon: Evidence from the 2016 national sentinel surveillance survey of HIV and syphilis. Plos One 14(4): e0208963.